Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 29 May 24 EFFECT Notice of effectiveness
- 23 May 24 POS AM Prospectus update (post-effective amendment)
- 21 Mar 24 424B3 Prospectus supplement
- 15 Mar 24 424B3 Prospectus supplement
- 14 Mar 24 424B3 Prospectus supplement
- 10 Jan 24 424B3 Prospectus supplement
- 28 Dec 23 424B3 Prospectus supplement
- 28 Dec 23 EFFECT Notice of effectiveness
- 26 Dec 23 S-1/A IPO registration (amended)
- 21 Dec 23 S-1/A IPO registration (amended)
- 15 Dec 23 S-1/A IPO registration (amended)
-
13 Dec 23 S-1 IPO registration
BTTX similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Registration Statement on Form S-1 of Better Therapeutics, Inc. of our report dated March 30, 2023, relating to the financial statements of Better Therapeutics, Inc., as of and for the years ended December 31, 2022 and 2021 appearing elsewhere in this Registration Statement.
We also consent to the reference of our firm under the heading “Experts” in such Registration Statement.
/s/ Elliott Davis, LLC
Greenville, South Carolina
December 13, 2023